Wes Streeting’s row with pharma firms grows as talks end on NHS drug pricing
by Joanna Partridge from World news | The Guardian on (#6ZG84)
Drugmakers reject health secretary's latest offer, meaning unsustainable' rebate scheme will stay in place
A row between Wes Streeting and pharmaceutical companies has intensified after drugmakers rejected the health secretary's latest offer on NHS drug pricing.
Talks broke up without agreement on Friday, meaning the mechanism under which the health service claws back some of the money it pays for medicines will continue at a rate the industry has called unsustainable" and says could discourage companies from making investments in the UK.
Continue reading...